[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-338348-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-338348-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","modelling-bone-metastasis-in-spheroids-to-study-cancer-progression-and-screen-cisplatin-efficacy","Modelling bone metastasis in spheroids to study cancer progression and screen cisplatin efficacy","","Most bone metastases originate when primary breast or prostate cancer cells colonize the bone microenvironment, disrupting bone physiology and lowering 5-year survival to 10% and 6%. Reliable, predictive in vitro models are needed to evaluate emerging therapies because current 2D mono-culture systems fail to reflect clinical efficacy. A human 3D spheroid-based co-culture model was engineered to quantify cancer–bone marrow stromal cell dynamics and test cisplatin specificity.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/modelling-bone-metastasis-in-spheroids-to-study-cancer-progression-and-screen-cisplatin-efficacy/338348/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/modelling-bone-metastasis-in-spheroids-to-study-cancer-progression-and-screen-cisplatin-efficacy/338348.png","ImageObject",300,407,{"name":42,"@type":43},"Sage","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are current 2D in vitro models insufficient for bone metastasis therapy screening?","Question",{"text":63,"@type":64},"They do not accurately predict clinical efficacy, motivating the need for more reliable, predictive in vitro systems.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What 3D model approach was engineered in this study?",{"text":68,"@type":64},"A human in vitro 3D co-culture model based on spheroids was built to study dynamic interactions between cancer cells (breast or prostate) and human bone marrow stromal cells.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the study find about cisplatin response in the bone metastatic spheroid model?",{"text":72,"@type":64},"Cancer cells proliferated faster and were less susceptible to cisplatin in the spheroid model than in 2D control cultures.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},338348,1790185763,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","DOI: 10.1111/cpr.13693  \nO R IG INA L ARTI CLE  \nModelling bone metastasis in spheroids to study cancer progression and screen cisplatin efficacy  \nCeri-Anne E. Suurmond  | Sander C. G. Leeuwenburgh  | Jeroen J. J. P. van den Beucken   \nDentistry—Regenerative Biomaterials, Radboudumc, Nijmegen, The Netherlands  \nCorrespondence  \nJeroen J. J. P. van den Beucken, Dentistry—Regenerative Biomaterials (309), Radboudumc, Philips van Leijdenlaan 25, 6525EX Nijmegen, The Netherlands.  \nEmail: [jeroen.vandenbeucken@radboudumc.nl](jeroen.vandenbeucken@radboudumc.nl)  \nFunding information  \nNederlandse Organisatie voor Wetenschappelijk Onderzoek, Grant/Award Number: 17835  \nAbstract  \nMost bone metastases are caused by primary breast or prostate cancer cells settling in the bone microenvironment, affecting normal bone physiology and function and reducing 5-year survival rates to 10% and 6%, respectively. To expedite clinical availability of novel and effective bone metastases treatments, reliable and predictive in vitro models are urgently required to screen for novel therapies as current in vitro 2D planar mono-culture models do not accurately predict the clinical efficacy. We herein engineered a novel human in vitro 3D co-culture model based on spheroids to study dynamic cellular quantities of (breast or prostate) cancer cells and human bone marrow stromal cells and screen chemotherapeutic efficacy and specificity of the common anticancer drug cisplatin. Bone metastatic spheroids (BMSs) were formed rapidly within 24 h, while the morphology of breast versus prostate cancer BMS differed in terms of size and circularity upon prolonged culture periods. Prestaining cell types prior to BMS formation enabled confocal imaging and quantitative image analysis of in-spheroid cellular dynamics for up to 7 days of BMS culture. We found that cancer cells in BMS proliferated faster and were less susceptible to cisplatin treatment compared to 2D control cultures. Based on these findings and the versatility of our methodology, BMS represent a feasible 3D in vitro model for screening of new bone cancer metastases therapies.  \n1 | INTRODUCTION  \nBone metastases are very painful cancer lesions caused by cancer cells that have metastasised from primary cancers, most often breast (70% metastasising to bone) or prostate (85% metastasising to bone) cancers.1 Once a breast or prostate cancer patient is diagnosed with bone metastases, 5-year survival rates drop to 10% and 6%, respectively.2,3 Cancer cells that cause bone metastases have some plasticity in the epithelial to mesenchymal transition to disseminate and subsequently extravasate into the bone microenvironment.4 This extravasation into bone is postulated to be facilitated by discontinuous  \nendothelium in bone sinusoids, which partly explains the high incidence of metastases in bone compared to other organs.5 Subsequently, cancer cells in the bone microenvironment need to escape dormancy to mature as metastatic lesions.4 The bone microenvironment is a fertile soil for metastasis of cancer cells for several reasons. First, the haematopoietic environment, which normally nurtures haematopoietic stem cells, is hijacked by the plastic cancer cells. Second, the abundancy of growth factors in the bone microenvironment stimulates cancer cells, leading to the so-called vicious cycle of bone metastases. 1,5–7 Based on the specific effects of cancer cells on various bone cells, bone metastases are either classified as osteolytic,  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2024 The Author(s) . Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.  \nCell Prolif. 2024;57:e13693 .  \n[https://doi.org/10.1111/cpr.13693](https://doi.org/10.1111/cpr.13693)  \n[onlinelibrary.wiley.com/journal/136521","cbCaicln74JQ8tKh","https://ap.wps.com/l/cbCaicln74JQ8tKh","pdf",6837084,15,"English","# Introduction\n## Bone metastases burden and survival impact\n## Mechanisms of dissemination and bone microenvironment\n## Clinical challenges in treatment efficacy and modeling","[{\"question\":\"Why are current 2D in vitro models insufficient for bone metastasis therapy screening?\",\"answer\":\"They do not accurately predict clinical efficacy, motivating the need for more reliable, predictive in vitro systems.\"},{\"question\":\"What 3D model approach was engineered in this study?\",\"answer\":\"A human in vitro 3D co-culture model based on spheroids was built to study dynamic interactions between cancer cells (breast or prostate) and human bone marrow stromal cells.\"},{\"question\":\"What did the study find about cisplatin response in the bone metastatic spheroid model?\",\"answer\":\"Cancer cells proliferated faster and were less susceptible to cisplatin in the spheroid model than in 2D control cultures.\"}]","Modelling bone metastasis in spheroids to study cancer progression and screen cisplatin efficacy | PDF",1790023169,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/81d4e2a59b678e8e3873467f392a1d4f.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e7cc77902b25bcbae8ed494f8efa6a7c.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dfe293026dd256f948e3d456a771b8e3.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/907772da9a2ed7369497e1c0af17768a.webp",980,1287]